Hyperthermic intraperitoneal chemotherapy with oxaliplatin—Still not the standard of care for patients with colorectal peritoneal metastases

Benzer Materyaller

• Reply to ‘Hyperthermic intraperitoneal chemotherapy with oxaliplatin—Still not standard of care for patients with colorectal peritoneal metastases’ by Julianov and Saroglu
  Yazar:: de Jong, Loek A.W., ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer
  Yazar:: Spiegelberg, Julia, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy
  Yazar:: Ubink, I., ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• The importance of synchronicity in the management of colorectal peritoneal metastases with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
  Yazar:: Wong, Jolene Si Min, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal metastases
  Yazar:: Mirnezami, Reza, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)